RADIOTHERAPIE

CENTRUM RADIOTHERAPIE

ARTIKELS

ABSTRACT 1

Oligometastatic prostate cancer: The game is afoot.

Lancia A, Zilli T, Liefhooghe N, et al. Cancer Treatment Reviews, 2019, volume 73, 84-90

INTRODUCTION/BACKGROUND Oligometastatic prostate cancer represents an intermediate state between a localized tumor and widespread metastatic disease. Its specific clinical features suggest the existence of a distinct biology which still needs to be elucidated. New imaging techniques like prostate specific membrane antigen (PSMA) PET scans have shown to perform well in the staging and restaging of this category of patients, at different phases of disease evolution. Despite limited prospective evidence, metastasis-directed therapies (MDT) are emerging as valid treatment options able to postpone systemic therapies and probably improve survival outcome. The aim of this review is to shed light on the clinical scenario of prostate cancer patients with limited metastatic disease burden and highlight the role of MDT strategies in this setting. ABSTRACT 2

The financial impact of SBRT for oligometastatic disease: A population-level analysis in Belgium.

Radiotherapy and Oncology, 2020, 145, 215-222 Het abstract is terug te vinden op pagina 53. ABSTRACT 3

Underrepresentation of vulnerable older patients with cancer in phase II and III oncology registration trials: A case-control study. Tack L, Debruyne P, Ketelaars L, De Zutter J, Martens E, Stellamans K, Van Eygen K, Werbrouck P, Vergauwe P,

et al. Journal of Geriatric Oncology, 2020, 11(2), 320-326 Het abstract is te vinden op pagina 50.

PRESENTATIES/ CONGRESSEN

ABSTRACT 1

Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer.

American Society for Radiation Oncology (ASTRO) Van der Vorst A, Kindts I, Laenen A, Janssens H, et al. September 2019, Chicago – USA

Nevens D, Lievens Y, Kindts I, et al.

Het abstract is te vinden op pagina 54.